Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$36.06 - $69.85 $5.1 Million - $9.87 Million
141,312 New
141,312 $6.31 Million
Q2 2022

Aug 15, 2022

SELL
$21.74 - $46.75 $1.15 Million - $2.47 Million
-52,874 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$23.7 - $41.39 $940,795 - $1.64 Million
-39,696 Reduced 42.88%
52,874 $2.19 Million
Q4 2021

Feb 14, 2022

BUY
$30.7 - $43.36 $2.19 Million - $3.09 Million
71,370 Added 336.65%
92,570 $3.5 Million
Q3 2021

Nov 15, 2021

BUY
$19.91 - $68.26 $422,092 - $1.45 Million
21,200 New
21,200 $699,000
Q2 2021

Aug 16, 2021

SELL
$50.63 - $73.5 $8.19 Million - $11.9 Million
-161,801 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$55.91 - $81.44 $8.16 Million - $11.9 Million
145,901 Added 917.62%
161,801 $9.16 Million
Q4 2020

Feb 16, 2021

BUY
$66.31 - $86.52 $1.05 Million - $1.38 Million
15,900 New
15,900 $1.3 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.45B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.